Immunogenic cell death of breast cancer stem cells induced by an endoplasmic reticulum‐targeting copper (II) Complex
P Kaur, A Johnson, J Northcote‐Smith, C Lu… - …, 2020 - Wiley Online Library
Immunogenic cell death (ICD) offers a method of stimulating the immune system to attack
and remove cancer cells. We report a copper (II) complex containing a Schiff base ligand …
and remove cancer cells. We report a copper (II) complex containing a Schiff base ligand …
Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells
E Beyranvand Nejad, TC van der Sluis, S van Duikeren… - Cancer research, 2016 - AACR
Certain cytotoxic chemotherapeutic drugs are immunogenic, stimulating tumor immunity
through mechanisms that are not completely understood. Here we show how the DNA …
through mechanisms that are not completely understood. Here we show how the DNA …
Mechanisms of translocation of ER chaperones to the cell surface and immunomodulatory roles in cancer and autoimmunity
Endoplasmic reticulum (ER) chaperones (eg, calreticulin, heat shock proteins, and
isomerases) perform a multitude of functions within the ER. However, many of these …
isomerases) perform a multitude of functions within the ER. However, many of these …
Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung …
JIG Solari, E Filippi-Chiela, ES Pilar, V Nunes… - BMC cancer, 2020 - Springer
Background Chemotherapeutics can stimulate immune antitumor response by inducing
immunogenic cell death (ICD), which is activated by Damage-Associated Molecular Patterns …
immunogenic cell death (ICD), which is activated by Damage-Associated Molecular Patterns …
Multifunctional Nano‐Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death
Immunotherapy is considered to be one of the most promising methods to overcome cancer.
Immunogenic cell death (ICD), as a special form of cell death that can trigger an antitumor …
Immunogenic cell death (ICD), as a special form of cell death that can trigger an antitumor …
Necroptosis-dependent immunogenicity of cisplatin: implications for enhancing the radiation-induced abscopal effect
R Luo, K Onyshchenko, L Wang, S Gaedicke… - Clinical Cancer …, 2023 - AACR
Purpose: Cisplatin is increasingly used in chemoimmunotherapy and may enhance the T
cell–dependent radiation-induced abscopal effect, but how it promotes antitumor immunity is …
cell–dependent radiation-induced abscopal effect, but how it promotes antitumor immunity is …
Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
F Radogna, M Diederich - Biochemical pharmacology, 2018 - Elsevier
Cancer is evading the host's defense mechanisms leading to avoidance of immune
destruction. During tumor progression, immune-evading cancer cells arise due to selective …
destruction. During tumor progression, immune-evading cancer cells arise due to selective …
Anticancer metal drugs and immunogenic cell death
A Terenzi, C Pirker, BK Keppler, W Berger - Journal of inorganic …, 2016 - Elsevier
Conventional chemotherapeutics, but also innovative precision anticancer compounds, are
commonly perceived to target primarily the cancer cell compartment. However, recently it …
commonly perceived to target primarily the cancer cell compartment. However, recently it …
Neoadjuvant chemotherapy modulates the immune microenvironment in metastases of tubo-ovarian high-grade serous carcinoma
S Böhm, A Montfort, OMT Pearce, J Topping… - Clinical Cancer …, 2016 - AACR
Purpose: The purpose of this study was to assess the effect of neoadjuvant chemotherapy
(NACT) on immune activation in stage IIIC/IV tubo-ovarian high-grade serous carcinoma …
(NACT) on immune activation in stage IIIC/IV tubo-ovarian high-grade serous carcinoma …
Combining antibody–drug conjugates and immune-mediated cancer therapy: what to expect?
HP Gerber, P Sapra, F Loganzo, C May - Biochemical pharmacology, 2016 - Elsevier
Blockade of immune-checkpoints has emerged as one of the most promising approaches to
improve the durability of anti-tumor responses in cancer patients. However, the fraction of …
improve the durability of anti-tumor responses in cancer patients. However, the fraction of …